Hrt Financial LP Fennec Pharmaceuticals Inc. Transaction History

Hrt Financial LP

  • $15.6 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$7.38 - $10.35 $403,206 - $565,472
54,635 New
54,635 $454,000
Q4 2021

Feb 14, 2022
SELL
$3.89 - $10.01 $217,587 - $559,909
-55,935 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.51 - $9.62 $39,418 - $58,249
-6,055 Reduced 9.77%
55,935 $526,000
Q2 2021

Aug 16, 2021
BUY
$5.96 - $7.85 $369,460 - $486,621
61,990 New
61,990 $451,000

Others Institutions Holding FENC

# of Institutions
69
Shares Held
14.4M
Call Options Held
53.2K
Put Options Held
83.9K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $157M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email